Hillson, J., Mant, T., Rosano, M., Huntenburg, C., Alai‐Safar, M., Darne, S., . . . Ganguly, T. (2018). Pharmacokinetic equivalence, comparable safety, and immunogenicity of an adalimumab biosimilar product (M923) to Humira in healthy subjects. Pharmacol Res Perspect.
Chicago Style CitationHillson, Jan, et al. "Pharmacokinetic Equivalence, Comparable Safety, and Immunogenicity of an Adalimumab Biosimilar Product (M923) to Humira in Healthy Subjects." Pharmacol Res Perspect 2018.
MLA CitationHillson, Jan, et al. "Pharmacokinetic Equivalence, Comparable Safety, and Immunogenicity of an Adalimumab Biosimilar Product (M923) to Humira in Healthy Subjects." Pharmacol Res Perspect 2018.
Warning: These citations may not always be 100% accurate.